Jennifer K. Moses

Insider Reports History

Location
Research Triangle Park, NC
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer K. Moses:

Company Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. CFO Common Stock 57,820 $170,124 $2.94 05 Jan 2023 Direct
G1 Therapeutics, Inc. CFO Stock Options (Right to buy) 44,600 03 Jan 2023 Direct
Viridian Therapeutics, Inc.\DE Director Stock Option (Right to Buy) 21,000 01 Jul 2025 Direct

Insider Reports Filed by Jennifer K. Moses

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRDN Viridian Therapeutics, Inc.\DE 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 16:43
VRDN Viridian Therapeutics, Inc.\DE 26 Jun 2024 1 $0 4 Director 28 Jun 2024, 16:05
VRDN Viridian Therapeutics, Inc.\DE 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 19:54
/report/000156218023000255-moses-jennifer-k-2023-01-03 G1 Therapeutics, Inc. 03 Jan 2023 4 -$13,080 4 CFO 05 Jan 2023, 19:26
VRDN Viridian Therapeutics, Inc.\DE 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 07:30
/report/000156218022000956-moses-jennifer-k-2022-02-01 G1 Therapeutics, Inc. 01 Feb 2022 4 +$9,579 4 CFO 02 Feb 2022, 16:20
/report/000156218022000306-moses-jennifer-k-2022-01-03 G1 Therapeutics, Inc. 03 Jan 2022 3 -$15,334 4 CFO 05 Jan 2022, 19:25
VRDN Viridian Therapeutics, Inc.\DE 14 Jul 2021 1 $0 4 Director 15 Jul 2021, 16:24
VRDN Viridian Therapeutics, Inc.\DE 14 Jul 2021 0 $0 3 Director 15 Jul 2021, 16:21